Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 1
2017 1
2020 1
2021 1
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Programmed Death Ligand 1: Unveiling its Impact on Endometrial Carcinogenesis.
Koutras A, Fasoulakis Z, Mollaki V, Perros P, Theodoulidis V, Syllaios A, Garmpis N, Kontomanolis EN. Koutras A, et al. Among authors: theodoulidis v. Cancer Diagn Progn. 2024 Jan 3;4(2):91-96. doi: 10.21873/cdp.10292. eCollection 2024 Mar-Apr. Cancer Diagn Progn. 2024. PMID: 38434913 Free PMC article. Review.
Primary retroperitoneal echinococcal cyst.
Gavriilidis P, Ananiadis A, Theodoulidis V, Barbanis S. Gavriilidis P, et al. Among authors: theodoulidis v. BMJ Case Rep. 2012 Nov 15;2012:bcr2012006465. doi: 10.1136/bcr-2012-006465. BMJ Case Rep. 2012. PMID: 23162021 Free PMC article.
Ovarian metastasis from breast invasive ductal carcinoma.
Gavriilidis P, Ananiadis A, Theodoulidis V, Toskas I, Barbanis S. Gavriilidis P, et al. Among authors: theodoulidis v. Hippokratia. 2012 Oct;16(4):391. Hippokratia. 2012. PMID: 23935333 Free PMC article. No abstract available.
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).
Gultekin M, Ak S, Ayhan A, Strojna A, Pletnev A, Fagotti A, Perrone AM, Erzeneoglu BE, Temiz BE, Lemley B, Soyak B, Hughes C, Cibula D, Haidopoulos D, Brennan D, Cola E, van der Steen-Banasik E, Urkmez E, Akilli H, Zapardiel I, Tóth I, Sehouli J, Zalewski K, Bahremand K, Chiva L, Mirza MR, Papageorgiou M, Zoltan N, Adámková P, Morice P, Garrido-Mallach S, Akgor U, Theodoulidis V, Arik Z, Steffensen KD, Fotopoulou C. Gultekin M, et al. Among authors: theodoulidis v. Cancer Med. 2021 Jan;10(1):208-219. doi: 10.1002/cam4.3605. Epub 2020 Nov 18. Cancer Med. 2021. PMID: 33205595 Free PMC article.
The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer.
Zouzoulas D, Tsolakidis D, Tzitzis P, Sofianou I, Chatzistamatiou K, Theodoulidis V, Topalidou M, Timotheadou E, Grimbizis G. Zouzoulas D, et al. Among authors: theodoulidis v. Cancers (Basel). 2024 Mar 24;16(7):1266. doi: 10.3390/cancers16071266. Cancers (Basel). 2024. PMID: 38610943 Free PMC article.